In a recent report, IFN-γ was found to be increased in CSF from patients with MS, whereas increased IL-17 was detected in serum [14], suggesting that the Th1 response plays a more critical role in orchestrating the MS immunopathological cascade. Here, IL17A is linked to myeloid sarcoma.